Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Omer Iqbal"'
Publikováno v:
Ain Shams Engineering Journal, Vol 15, Iss 9, Pp 102932- (2024)
The initial concept of an Unmanned Aerial Vehicle (UAV) design is complicated and unique due to performance parameters like payload capacity, engine power, endurance, service altitude, etc. required to perform a wide range of missions. Empirical corr
Externí odkaz:
https://doaj.org/article/5ff28b97560047e0a76c4c4232cecf9b
Autor:
Fakiha Siddiqui BDS, Alfonso Tafur MD, MS, MBA, Amir Darki MD, Bulent Kantarcioglu MD, Debra Hoppensteadt PhD, Emily Krupa BS, Omer Iqbal MD, Jawed Fareed PhD, Manuel Monreal MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Pulmonary embolism (PE) is a heterogenous condition with variable clinical presentations. Thrombin generation potential (TGP) and biomarkers, and blood cellular indices can reflect the underlying pathophysiology and risk stratification of PE. This ca
Externí odkaz:
https://doaj.org/article/59c1ad82c4924d33aa568ed856fbda76
Autor:
Srdjan Nikolovski, Branislava Medic Brkic, Katarina Savic Vujovic, Ivana Cirkovic, Nina Jovanovic, Bhavana Reddy, Omer Iqbal, Chongyu Zhang, Jawed Fareed, Vinod Bansal
Publikováno v:
Diagnostics, Vol 14, Iss 21, p 2406 (2024)
Background/Objectives: Besides a multitude of consequences patients on chronic renal replacement therapy have, anemia is one of the most prominent factors making a significant number of patients dependent on erythropoiesis-stimulating agent (ESA) the
Externí odkaz:
https://doaj.org/article/ae9fb517c87440c6886608e4636cd847
Autor:
Guy Olson BS, Walter Jeske PhD, Omer Iqbal MD, Emily Krupa BS, Amber Farooqui MD, Fakiha Siddiqui BDS, Debra Hoppensteadt PhD, Ahmed Kouta PhD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Introduction: Bovine and ovine mucosa represent alternate anticoagulants to porcine mucosa for production of unfractionated heparin (UFH). Standardized heparins from various sources can be blended and potency adjusted, blended heparins exhibit compar
Externí odkaz:
https://doaj.org/article/a22e14aa5cf148389f9dbf9a742d529d
Autor:
Yevgeniy Brailovsky DO, MSc, Vladimir Lakhter DO, Joshua Newman MD, Sorcha Allen MBBCh, Ahmed Elkaryoni MD, Parth Desai MD, Dalila Masic PharmD, Carlos F. Bechara MD, Emily Bontekoe BS, Debra Hoppensteadt PhD, John J. Lopez MD, Fakiha Siddiqui BDS, Omer Iqbal PhD, Jawed Fareed PhD, Amir Darki, MD, MSc
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Background Acute pulmonary embolism (PE) is a heterogeneous disease process with variable presentation and outcomes. The endogenous fibrinolytic system is a complex framework of regulatory pathways that maintains homeostasis by dissolving overabundan
Externí odkaz:
https://doaj.org/article/7f1e6de3abd5418699902e753ad986f7
Autor:
Mohammed Abourahma BS, Wajahat Mohammed BS, Bulent Kantarcioglu MD, Atul Laddu MD, PhD, Omer Iqbal MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Externí odkaz:
https://doaj.org/article/74ee46da09954054ab584c0fefb8d65d
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
IntroductionDrawing on the assumptions of approach/inhibition theory of power and conservation of resource of theory, this study aims to empirically explore the relationship between fear of losing power and knowledge hiding. To explicate the relation
Externí odkaz:
https://doaj.org/article/7ef9b3ce787946f6b57ee7fd7fa4f53b
Autor:
Siddharth Mehrotra, Debra Hoppensteadt PhD, Walter Jeske PhD, Fakiha Siddiqui BS, Omer Iqbal MD, Alfonso Tafur MD, Bruce Lewis MD, Mark Jaradeh BS, Bulent Kantarcioglu MD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Introduction The available oral anti-Xa agents are routinely used for the management of thrombotic disorders. A molecularly modified recombinant coagulation FXa, also known as Andexanet Alfa (AA), that has been developed as an antidote to neutralize
Externí odkaz:
https://doaj.org/article/ea1b4598519b4811bd1e31d03d5eacd1
Autor:
Bulent Kantarcioglu MD, Amir Darki MD, MSc, Fakiha Siddiqui BDS, Emily Krupa BS, Mehmet Vural MD, Murat Kacmaz MD, Debra Hoppensteadt PhD, Omer Iqbal MD, Walter Jeske PhD, Jeanine Walenga PhD, Cafer Adiguzel MD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Introduction In this study, we profiled the levels of blood cellular indices, endogenous glycosaminoglycans (GAGs) and inflammatory biomarkers in a cohort comprised of pulmonary embolism (PE) patients, to determine their inter-relationships. Identifi
Externí odkaz:
https://doaj.org/article/110980c3dd7e456e97b9d9aa585a6b9c
Autor:
Joseph Lewis BA, Omer Iqbal MD, Walter Jeske PhD, Debra Hoppensteadt PhD, Fakiha Siddiqui BDS, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Introduction Andexanet alfa (andexanet) is an approved antidote used to reverse the bleeding effects of Direct Oral Anticoagulant (Direct-Xa agents) agents because it reverses anti-Xa activity. Unfractionated heparin (UFH) and low molecular weight he
Externí odkaz:
https://doaj.org/article/898573021cb94fc8992380467d649964